These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8705902)

  • 1. Triple-marker screening for Down syndrome.
    Viner G
    CMAJ; 1996 Aug; 155(3):272; author reply 272-3. PubMed ID: 8705902
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple-marker screening for Down syndrome.
    Farrell SA; Chadwick DE; Summers AM; Wyatt PR
    CMAJ; 1996 Aug; 155(3):271-2; author reply 272-3. PubMed ID: 8705901
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

  • 5. Down's Syndrome screening: confusion or consensus?
    Goldberg JD
    BJOG; 2004 Jun; 111(6):517-8. PubMed ID: 15198776
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 7. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 9. Which contingent sequential screening protocol?
    Larsen SO; Christiansen M; Norgaard-Pedersen B
    Prenat Diagn; 2005 Dec; 25(12):1168-9; author reply 1169-70. PubMed ID: 16317663
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antenatal screening methods for chromosome 21 trisomy].
    Päkkilä M; Niemimaa M; Kirkinen P; Ryynänen M
    Duodecim; 2001; 117(3):269-74; quiz 274, 281. PubMed ID: 12092395
    [No Abstract]   [Full Text] [Related]  

  • 11. Growing complexity in the choice of Down's syndrome screening policy.
    Cuckle HS
    Ultrasound Obstet Gynecol; 2002 Apr; 19(4):323-6. PubMed ID: 11952957
    [No Abstract]   [Full Text] [Related]  

  • 12. Which prenatal screening protocol?
    Ferguson-Smith MA
    Prenat Diagn; 2004 Oct; 24(10):761. PubMed ID: 15503274
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in antenatal screening for Down syndrome.
    Wald NJ; Hackshaw AK
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):563-80. PubMed ID: 10985931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 16. Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan.
    Onda T; Tanaka T; Takeda O; Kitagawa M; Kuwabara Y; Yamamoto H; Iinuma K; Shimomura K
    Prenat Diagn; 1998 Sep; 18(9):956-8. PubMed ID: 9793980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schwangerschafts protein 1 (SP1) adds little to the age-related detection of fetal Down syndrome in the first trimester of pregnancy.
    Kornman LH; Morssink LP; Ten Hoor KA; De Wolf BT; Kloosterman MD; Beekhuis JR; Mantingh A
    Prenat Diagn; 1998 Oct; 18(10):1086-90. PubMed ID: 9826903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The triple test decision.
    Grayson A
    Mod Midwife; 1996 Aug; 6(8):16-9. PubMed ID: 8974672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.